<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2680806-A1" country="EP" doc-number="2680806" kind="A1" date="20140108" family-id="44262668" file-reference-id="318303" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146586855" ucid="EP-2680806-A1"><document-id><country>EP</country><doc-number>2680806</doc-number><kind>A1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12723256-A" is-representative="NO"><document-id mxw-id="PAPP154849047" load-source="docdb" format="epo"><country>EP</country><doc-number>12723256</doc-number><kind>A</kind><date>20120417</date><lang>EN</lang></document-id><document-id mxw-id="PAPP173226917" load-source="docdb" format="original"><country>EP</country><doc-number>12723256.9</doc-number><date>20120417</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140556750" ucid="IL-2012000164-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>IL</country><doc-number>2012000164</doc-number><kind>W</kind><date>20120417</date></document-id></priority-claim><priority-claim mxw-id="PPC140549696" ucid="IL-21242011-A" load-source="docdb"><document-id format="epo"><country>IL</country><doc-number>21242011</doc-number><kind>A</kind><date>20110417</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989316251" load-source="docdb">A61J   1/20        20060101AFI20121105BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2048000988" load-source="docdb" scheme="CPC">A61J   1/2055      20150501 LA20150507BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2048002001" load-source="docdb" scheme="CPC">A61J   1/2086      20150501 LA20150507BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2048003642" load-source="docdb" scheme="CPC">A61J   1/2013      20150501 LA20150507BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2048006362" load-source="docdb" scheme="CPC">A61J   1/2065      20150501 LA20150507BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2048006718" load-source="docdb" scheme="CPC">A61J   1/2072      20150501 LA20150507BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2048007130" load-source="docdb" scheme="CPC">A61J   1/201       20150501 LA20150507BHEP        </classification-cpc><classification-cpc mxw-id="PCL2003767715" load-source="docdb" scheme="CPC">A61J   1/2089      20130101 LI20140124BHEP        </classification-cpc><classification-cpc mxw-id="PCL2003767716" load-source="docdb" scheme="CPC">A61J   1/2096      20130101 FI20140124BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132365198" lang="DE" load-source="patent-office">ANORDNUNG ZUR ÜBERTRAGUNG VON FLÜSSIGMEDIKAMENTEN</invention-title><invention-title mxw-id="PT132365199" lang="EN" load-source="patent-office">LIQUID DRUG TRANSFER ASSEMBLY</invention-title><invention-title mxw-id="PT132365200" lang="FR" load-source="patent-office">ENSEMBLE DE TRANSFERT DE MÉDICAMENT LIQUIDE</invention-title><citations><non-patent-citations><nplcit><text>See references of WO 2012143921A1</text><sources><source mxw-id="PNPL67456182" load-source="docdb" name="SEA"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR919529096" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>MEDIMOP MEDICAL PROJECTS LTD</last-name><address><country>IL</country></address></addressbook></applicant><applicant mxw-id="PPAR919503791" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>MEDIMOP MEDICAL PROJECTS LTD</last-name></addressbook></applicant><applicant mxw-id="PPAR919007015" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Medimop Medical Projects Ltd</last-name><iid>101411940</iid><address><street>17 Hatidhar Street POBox 2499</street><city>43665 Ra'anana</city><country>IL</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919531011" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>DENENBURG IGOR</last-name><address><country>IL</country></address></addressbook></inventor><inventor mxw-id="PPAR919507262" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>DENENBURG, IGOR</last-name></addressbook></inventor><inventor mxw-id="PPAR919013993" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>DENENBURG, IGOR</last-name><address><street>50 Ofarim</street><city>70700 Gedera</city><country>IL</country></address></addressbook></inventor><inventor mxw-id="PPAR919519524" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>LEV NIMROD</last-name><address><country>IL</country></address></addressbook></inventor><inventor mxw-id="PPAR919511856" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>LEV, NIMROD</last-name></addressbook></inventor><inventor mxw-id="PPAR919010457" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>LEV, NIMROD</last-name><address><street>1 Havradim Street</street><city>56905 Savion</city><country>IL</country></address></addressbook></inventor><inventor mxw-id="PPAR919530002" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>BUKHMAN MORDECHAI</last-name><address><country>IL</country></address></addressbook></inventor><inventor mxw-id="PPAR919527922" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>BUKHMAN, Mordechai</last-name></addressbook></inventor><inventor mxw-id="PPAR919016380" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>BUKHMAN, Mordechai</last-name><address><street>64/8 Irus Ha'argaman</street><city>42490 Netanya</city><country>IL</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR919017091" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>South, Nicholas Geoffrey</last-name><suffix>et al</suffix><iid>100049155</iid><address><street>A.A. Thornton &amp; Co. 235 High Holborn</street><city>London WC1V 7LE</city><country>GB</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="IL-2012000164-W"><document-id><country>IL</country><doc-number>2012000164</doc-number><kind>W</kind><date>20120417</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012143921-A1"><document-id><country>WO</country><doc-number>2012143921</doc-number><kind>A1</kind><date>20121026</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549765689" load-source="docdb">AL</country><country mxw-id="DS549777285" load-source="docdb">AT</country><country mxw-id="DS549765690" load-source="docdb">BE</country><country mxw-id="DS549766015" load-source="docdb">BG</country><country mxw-id="DS549845302" load-source="docdb">CH</country><country mxw-id="DS549916864" load-source="docdb">CY</country><country mxw-id="DS549777286" load-source="docdb">CZ</country><country mxw-id="DS549765691" load-source="docdb">DE</country><country mxw-id="DS549916865" load-source="docdb">DK</country><country mxw-id="DS549916866" load-source="docdb">EE</country><country mxw-id="DS549847281" load-source="docdb">ES</country><country mxw-id="DS549766016" load-source="docdb">FI</country><country mxw-id="DS549846999" load-source="docdb">FR</country><country mxw-id="DS549765692" load-source="docdb">GB</country><country mxw-id="DS549916867" load-source="docdb">GR</country><country mxw-id="DS549765697" load-source="docdb">HR</country><country mxw-id="DS549777287" load-source="docdb">HU</country><country mxw-id="DS549845303" load-source="docdb">IE</country><country mxw-id="DS549916868" load-source="docdb">IS</country><country mxw-id="DS549847000" load-source="docdb">IT</country><country mxw-id="DS549916869" load-source="docdb">LI</country><country mxw-id="DS549766021" load-source="docdb">LT</country><country mxw-id="DS549861141" load-source="docdb">LU</country><country mxw-id="DS549766022" load-source="docdb">LV</country><country mxw-id="DS549766023" load-source="docdb">MC</country><country mxw-id="DS549861150" load-source="docdb">MK</country><country mxw-id="DS549861151" load-source="docdb">MT</country><country mxw-id="DS549847286" load-source="docdb">NL</country><country mxw-id="DS549847001" load-source="docdb">NO</country><country mxw-id="DS549861152" load-source="docdb">PL</country><country mxw-id="DS549845304" load-source="docdb">PT</country><country mxw-id="DS549847287" load-source="docdb">RO</country><country mxw-id="DS549845305" load-source="docdb">RS</country><country mxw-id="DS549861153" load-source="docdb">SE</country><country mxw-id="DS549765698" load-source="docdb">SI</country><country mxw-id="DS549847010" load-source="docdb">SK</country><country mxw-id="DS549861282" load-source="docdb">SM</country><country mxw-id="DS549916870" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><abstract mxw-id="PA101346488" ref-ucid="WO-2012143921-A1" lang="EN" load-source="patent-office"><p num="0000">Liquid drug transfer assemblies (100A) for use with a drug vial (20) having a drug vial opening (23) stopped by a drug vial stopper (24). The liquid drug transfer assemblies (100A) include a drug vial stopper puncturing member (110) for puncturing a drug vial stopper (24). The liquid drug transfer assemblies (100A) also include a drug vial adapter (120) having a drug vial adapter skirt (122), an upright drug vial adapter port (124) and a drug vial adapter sleeve (131) downward depending opposite the upright drug vial adapter port (124) and in flow communication therewith. The drug vial adapter (120) is slidingly disposed on the drug vial stopper puncturing member (110) such that on mounting the liquid drug transfer assembly (100A) on the drug vial (20), the drug vial stopper puncturing member (110) punctures the drug vial stopper (24) to form a throughgoing puncture bore P and the drug vial adapter sleeve (131) lines the puncture bore P.</p></abstract><abstract mxw-id="PA101776688" ref-ucid="WO-2012143921-A1" lang="EN" source="national office" load-source="docdb"><p>Liquid drug transfer assemblies (100A) for use with a drug vial (20) having a drug vial opening (23) stopped by a drug vial stopper (24). The liquid drug transfer assemblies (100A) include a drug vial stopper puncturing member (110) for puncturing a drug vial stopper (24). The liquid drug transfer assemblies (100A) also include a drug vial adapter (120) having a drug vial adapter skirt (122), an upright drug vial adapter port (124) and a drug vial adapter sleeve (131) downward depending opposite the upright drug vial adapter port (124) and in flow communication therewith. The drug vial adapter (120) is slidingly disposed on the drug vial stopper puncturing member (110) such that on mounting the liquid drug transfer assembly (100A) on the drug vial (20), the drug vial stopper puncturing member (110) punctures the drug vial stopper (24) to form a throughgoing puncture bore P and the drug vial adapter sleeve (131) lines the puncture bore P.</p></abstract><abstract mxw-id="PA101346489" ref-ucid="WO-2012143921-A1" lang="FR" load-source="patent-office"><p num="0000">L'invention concerne des ensembles (100A) de transfert de médicament liquide destinés à être utilisés avec un flacon à médicament (20) présentant une ouverture (23) fermée par un bouchon (24) de flacon à médicament. Les ensembles (100A) de transfert de médicament liquide comprennent un perforateur (110) de bouchon du flacon à médicament pour percer un bouchon (24) de flacon à médicament. Les ensembles (100A) de transfert de médicament liquide comprennent aussi un adaptateur (120) de flacon à médicament muni d'une jupe (122) d'adaptateur de flacon à médicament, un orifice (124) d'adaptateur de flacon à médicament vertical et un manchon (131) d'adaptateur de flacon à médicament s'étendant vers le bas à l'opposé de l'orifice (124) d'adaptateur de flacon à médicament vertical et en communication fluidique avec celui-ci. Un adaptateur (120) de flacon à médicament est disposé de manière coulissante sur le perforateur (110) du bouchon de flacon à médicament de telle sorte que, lorsque l'ensemble (100A) de transfert de médicament liquide est monté sur le flacon à médicament (20), le perforateur (110) du bouchon de flacon à médicament perce le bouchon (24) du flacon à médicament pour y former un alésage P de perforation traversant et que le manchon (131) d'adaptateur de flacon à médicament garnisse l'alésage P de perforation.</p></abstract><abstract mxw-id="PA101776689" ref-ucid="WO-2012143921-A1" lang="FR" source="national office" load-source="docdb"><p>L'invention concerne des ensembles (100A) de transfert de médicament liquide destinés à être utilisés avec un flacon à médicament (20) présentant une ouverture (23) fermée par un bouchon (24) de flacon à médicament. Les ensembles (100A) de transfert de médicament liquide comprennent un perforateur (110) de bouchon du flacon à médicament pour percer un bouchon (24) de flacon à médicament. Les ensembles (100A) de transfert de médicament liquide comprennent aussi un adaptateur (120) de flacon à médicament muni d'une jupe (122) d'adaptateur de flacon à médicament, un orifice (124) d'adaptateur de flacon à médicament vertical et un manchon (131) d'adaptateur de flacon à médicament s'étendant vers le bas à l'opposé de l'orifice (124) d'adaptateur de flacon à médicament vertical et en communication fluidique avec celui-ci. Un adaptateur (120) de flacon à médicament est disposé de manière coulissante sur le perforateur (110) du bouchon de flacon à médicament de telle sorte que, lorsque l'ensemble (100A) de transfert de médicament liquide est monté sur le flacon à médicament (20), le perforateur (110) du bouchon de flacon à médicament perce le bouchon (24) du flacon à médicament pour y former un alésage P de perforation traversant et que le manchon (131) d'adaptateur de flacon à médicament garnisse l'alésage P de perforation.</p></abstract><description mxw-id="PDES52190982" ref-ucid="WO-2012143921-A1" lang="EN" load-source="patent-office"><!-- EPO <DP n="3"/>--><p id="p0001" num="0001"> LIQUID DRUG TRANSFER ASSEMBLY</p><p id="p0002" num="0002">Field of the Invention </p><p id="p0003" num="0003"> The invention relates to liquid drag transfer assemblies for liquid drug reconstitution and administration purposes. </p><p id="p0004" num="0004">Background of the Invention </p><p id="p0005" num="0005"> Dual ended dual lumen linear transfer spikes are typically employed for gravitational liquid transfer from a liquid vial containing a liquid component to a drug vial containing a drug component for forming liquid drug contents in the drug vial for administration purposes and simultaneous air transfer from the drug vial to the liquid vial for pressure equalization. The transfer spikes have exposed drug vial stopper and liquid vial stopper puncturing members with sharp vial stopper puncturing tips which pose a danger to users in general and home users in particular. Moreover, it is difficult to accurately center and correctly insert a transfer spike on a vial stopper to ensure that the transfer spike correctly punctures same for flow communication with a vial interior. Furthermore, a user has to manually remove the transfer spike and use other means, for example, a needle, to withdraw the liquid drug contents which can be cumbersome action and lead to a needle stick injury and contamination of the liquid drug contents. </p><p id="p0006" num="0006">Summary of the Invention </p><p id="p0007" num="0007"> The invention relates to liquid drug transfer assemblies for use with a drug vial including a drug vial bottle containing a drug component and having a drug vial opening stopped by a drug vial stopper. The drug component is typically a powdered drug component but can equally be a liquid drug component of different viscosities. The liquid drug transfer assemblies include a drug vial stopper puncturing member and a drug vial adapter having a substantially cylindrical drug vial adapter skirt with a drug vial adapter top surface, a drug vial adapter body portion for telescopically slidingly receiving a 
<!-- EPO <DP n="4"/>-->
 drug vial opening therein and a drug vial adapter skirt margin. The drug vial adapter top surface is formed with an upright drug vial adapter port and a downward depending drug vial adapter sleeve opposite the drug vial adapter port and in flow communication therewith. The drug vial adapter skirt can be optionally formed from a multitude of at least two drug vial adapter flex members. The drug vial adapter skirt can optionally include inwardly directed protrusions for snap fitting onto a drug vial opening. The drug vial adapter skirt margin can be optionally outwardly flared with respect to the drug vial adapter body portion for assisting in guidance of the drug vial adapter on a drug vial. The drug vial adapter is slidingly disposed on the drug vial stopper puncturing member such that its drug vial stopper puncturing member protrudes beyond the drug vial adapter sleeve in a set-up position of the liquid drug transfer assembly. </p><p id="p0008" num="0008"> The liquid drug transfer assembly is mounted on a drug vial such that the drug vial stopper puncturing member punctures the drug vial stopper to form a throughgoing puncture bore and the drug vial adapter sleeve lines the puncture bore through the drug vial stopper. The drug vial adapter sleeve stops the drug vial stopper from sealing itself on withdrawal of the drug vial stopper puncturing member therefrom, thereby maintaining continuous flow communication between the drug vial bottle and the drug vial adapter port. The drug vial adapter sleeve also prevents remnants of the drug vial stopper contaminating liquid drug contents in a drug vial. Suitable medical devices can be readily mounted on the drug vial adapter port for flow communication with the drug vial bottle. Suitable medical devices include inter alia a needleless syringe, an administration line, and the like. </p><p id="p0009" num="0009"> The drug vial stopper puncturing member can be configured as one end of a dual ended dual lumen linear transfer spike including an opposite liquid vial stopper puncturing member for puncturing a liquid vial stopper of a liquid vial containing a liquid component. The liquid component is typically a diluent but can equally contain an active drug component. Such a dual ended dual lumen linear transfer spike enables simultaneous gravitational liquid transfer 
<!-- EPO <DP n="5"/>-->
 from a liquid vial to a drug vial for forming liquid drug contents in a drug vial for administration purposes and air transfer from the drug vial to the liquid vial for pressure equalization purposes. </p><p id="p0010" num="0010"> The dual ended dual lumen linear transfer spike can be integrally formed with a liquid vial adapter for mounting onto a liquid vial. Alternatively, the dual ended dual lumen linear transfer spike can be integrally formed with a liquid drug transfer device for use with a discrete liquid vial adapter for mounting onto a liquid vial thereby forming a triple component liquid drug transfer assembly including the drug vial adapter. The liquid drug transfer device includes a transverse directed spacing collar midway along the dual ended dual lumen linear transfer spike, at least two longitudinal directed drug vial legs and at least two longitudinal directed liquid vial legs oppositely directed to the at least two longitudinal directed drug vial legs. The drug vial legs and the liquid vial legs are employed for centering purposes of their corresponding drug vial stopper puncturing tip and liquid vial stopper puncturing tip with respect to their respective vial stoppers. </p><p id="p0011" num="0011">Brief Description of Drawings </p><p id="p0012" num="0012"> In order to understand the invention and to see how it can be carried out in practice, preferred embodiments will now be described, by way of non- limiting examples only, with reference to the accompanying drawings in which similar parts are likewise numbered, and in which: </p><p id="p0013" num="0013"> Fig. 1 is a pictorial representation of a first preferred embodiment of a liquid drug transfer assembly including a drug vial stopper puncturing member and a drug vial adapter, a blister pack for long term storage of same, a needleless syringe, and a drug vial; </p><p id="p0014" num="0014"> Fig. 2 is an exploded view of Figure l's liquid drug transfer assembly;</p><p id="p0015" num="0015">Fig. 3 is a longitudinal cross section of Figure l 's liquid drug transfer assembly in its initial ready to use state along line A- A in Figure 1; 
<!-- EPO <DP n="6"/>-->
 Fig. 4A is a longitudinal cross section of Figure l 's liquid drug transfer assembly in a set-up position and disposed co -axial with the drug vial ready for snap fitting thereon; </p><p id="p0016" num="0016"> Fig. 4B is a longitudinal cross section of Figure l 's liquid drug transfer assembly pursuant to an initial downward depression toward the drug vial; </p><p id="p0017" num="0017"> Fig. 4C is a longitudinal cross section of Figure l's liquid drug transfer assembly pursuant to complete snap fitting of the drug vial adapter on the drug vial; </p><p id="p0018" num="0018"> Fig. 4D is a longitudinal cross section of Figure l's liquid drug transfer assembly pursuant to removal of the drug vial stopper puncturing member; </p><p id="p0019" num="0019"> Fig. 5 is a longitudinal cross section of an alternative embodiment of Figure l 's liquid drug transfer assembly including a drug vial stopper puncturing member having a liquid drug access port and an in-line filter; </p><p id="p0020" num="0020"> Fig. 6 is a longitudinal cross section of another alternative embodiment of Figure l 's drug vial adapter including a drug vial adapter sleeve component mounted on its drug vial adapter top surface; </p><p id="p0021" num="0021"> Fig. 7 is a pictorial representation of a second preferred embodiment of a liquid drug transfer assembly including a liquid vial adapter and a drug vial adapter, a blister pack for long term storage of same, a needleless syringe, a drug vial, and a liquid vial; </p><p id="p0022" num="0022"> Fig. 8 is an exploded view of Figure 7's liquid drug transfer assembly; Fig. 9 is a longitudinal cross section of Figure 7's liquid drug transfer assembly in its initial ready to use state along line B-B in Figure 7; </p><p id="p0023" num="0023"> Fig. 10A shows Figure 7's liquid drug transfer assembly co-axial with a drug vial ready for snap fitting thereon; </p><p id="p0024" num="0024"> Fig. 10B shows Figure 7's liquid drug transfer assembly snap fitted on the drug vial; </p><p id="p0025" num="0025"> Fig. IOC shows inversion of the Figure 10B assemblage ready for snap fitting on the liquid vial; </p><p id="p0026" num="0026"> Fig. 10D shows the Figure 10B assemblage snap fitted on the liquid vial; 
<!-- EPO <DP n="7"/>-->
 Fig. 10E shows the Figure 10D assemblage in an inverted position for enabling gravitational liquid transfer from the liquid vial to the drug vial to form liquid drug contents in the drug vial and venting from the drug vial to the liquid vial; </p><p id="p0027" num="0027"> Fig. 10F shows the drug vial adapter mounted on the drug vial containing liquid drug contents after removal of the liquid drug vial with its attached empty liquid vial; and </p><p id="p0028" num="0028"> Fig. 10G shows use of the needleless syringe for aspirating liquid drug contents from the drug vial for administration purposes; </p><p id="p0029" num="0029"> Fig. 11 is a pictorial representation of a third preferred embodiment of a liquid drug transfer assembly including a liquid drug transfer device, a drug vial adapter, and a liquid vial adapter in its initial ready to use state, a blister pack for long term storage of same, a needleless syringe, a drug vial, and a liquid vial; </p><p id="p0030" num="0030"> Fig. 12 is a perspective view of Figure 11' s liquid drug transfer assembly; </p><p id="p0031" num="0031"> Fig. 13 is an exploded view of Figure ll's liquid drug transfer assembly and an enlarged transverse cross section of the dual ended dual lumen linear transfer spike of the liquid drug transfer device; </p><p id="p0032" num="0032"> Fig. 14 is a longitudinal cross section of Figure ll's liquid drug transfer assembly in its initial ready to use state along line C-C in Figure 11; </p><p id="p0033" num="0033"> Fig. 15A is a longitudinal cross section of Figure ll's liquid drug transfer assembly co-axial with the drug vial ready for snap fitting thereon; </p><p id="p0034" num="0034"> Fig. 15B is a longitudinal cross section of Figure ll's liquid drug transfer assembly pursuant to an initial downward depression of the liquid drug transfer assembly toward the drug vial; </p><p id="p0035" num="0035"> Fig. 15C is a longitudinal cross section of Figure ll's liquid drug transfer assembly pursuant to further downward depression of the liquid drug transfer assembly towards the drug vial; 
<!-- EPO <DP n="8"/>-->
 Fig. 15D is a longitudinal cross section of Figure ll's liquid drug transfer assembly pursuant to still further downward depression of the liquid drug transfer assembly towards the drug vial; </p><p id="p0036" num="0036"> Fig. 15E is a longitudinal cross section of Figure ll's liquid drug transfer assembly pursuant to complete snap fitting of the drug vial adapter on the drug vial; </p><p id="p0037" num="0037"> Fig. 15F is a longitudinal cross section of Figure ll's liquid drug transfer assembly showing complete snap fitting of both the drug vial and the liquid vial including snap fit engagement of the liquid drug transfer device and the liquid vial adapter; </p><p id="p0038" num="0038"> Fig. 16A shows Figure ll's liquid drug transfer assembly co-axial with a drug vial ready for snap fitting thereon; </p><p id="p0039" num="0039"> Fig. 16B shows Figure ll's liquid drug transfer assembly snap fitted on the drug vial; </p><p id="p0040" num="0040"> Fig. 16C shows inversion of the Figure 16B assemblage ready for snap fitting on the liquid vial; </p><p id="p0041" num="0041"> Fig. 16D shows the Figure 16B assemblage snap fitted on the liquid vial; </p><p id="p0042" num="0042"> Fig. 16E shows the Figure 16D assemblage in an inverted position for enabling gravitational liquid transfer from the liquid vial to the drug vial to form liquid drug contents in the drug vial and venting from the drug vial to the liquid vial; </p><p id="p0043" num="0043"> Fig. 16F shows the drug vial adapter mounted on the drug vial containing liquid drug contents after removal of the liquid drug transfer device and the liquid drug adapter with its attached empty liquid vial; and </p><p id="p0044" num="0044"> Fig. 16G shows use of the needleless syringe for aspirating liquid drug contents from the drug vial for administration purposes. </p><p id="p0045" num="0045">Detailed Description of Preferred Embodiments of the Invention </p><p id="p0046" num="0046"> Figure 1 shows a liquid drug transfer assembly 100A for use with a needleless syringe 10 and a drug vial 20. The syringe 10 includes a barrel 11 
<!-- EPO <DP n="9"/>-->
 with a plunger 12 and a male Luer lock connector 13. The syringe 10 can be formed with other types of male connectors. The syringe 10 is filled with a liquid component 14. The liquid component 14 can be diluent only. Alternatively, the liquid component 14 can include an active component. The drug vial 20 has a longitudinal drug vial axis 20A and includes a drug vial bottle 21 having a drug vial shoulder 22 and a drug vial opening 23 sealed by a drug vial stopper 24. The drug vial opening 23 has an uppermost outermost drug vial rim 26. The drug vial 20 contains a drug component 27. The liquid drug transfer assembly 100A is preferably packaged in a blister pack 101A having an internal surface 102 and a protective seal 103. </p><p id="p0047" num="0047"> Figures 1 to 3 show the liquid drug transfer assembly 100A includes a drug vial stopper puncturing member 110 having a longitudinal drug vial stopper puncturing member axis 111 and a drug vial adapter 120. The blister pack 101A is shaped and dimensioned to snugly fit the liquid drug transfer assembly 100A inside and employed for mounting same on the drug vial 20. The drug vial stopper puncturing member 110 has a drug vial stopper puncturing tip 112 for puncturing the drug vial stopper 24 and a transverse directed head 113. </p><p id="p0048" num="0048"> The drug vial adapter 120 has a longitudinal drug vial adapter axis 121 and includes a drug vial adapter skirt 122 having a transversely directed drug vial adapter top surface 123 formed with an upright drug vial adapter port 124 and a multitude of six downward depending drug vial adapter flex members 126. The drug vial adapter flex members 126 are provided with internal directed protrusions 127 for snap fitting under the drug vial opening 23 and define a drug vial adapter body portion 128 for snugly receiving the drug vial opening 23. The drug vial adapter flex members 126 define a drug vial adapter skirt margin 129 outwardly flared with respect to the drug vial adapter body portion 128 for assisting in guidance of the drug vial adapter 120 on the drug vial 20. The drug vial adapter port 124 is preferably implemented as a female Luer connector for screw thread engagement of the needleless syringe 10 thereon. Alternatively, the drug vial adapter port 124 can be formed with a 
<!-- EPO <DP n="10"/>-->
 wide diameter, for example, for enabling gravitational flow of viscous liquid drug contents from a drug vial 20. </p><p id="p0049" num="0049"> The drug vial adapter 120 also includes a downward depending drug vial adapter sleeve 131 opposite the drug vial adapter port 124 and in flow communication therewith. The drug vial adapter 120 including the drug vial adapter port 124 and the drug vial adapter sleeve 131 can be formed as a single injection plastic molded unit from the same suitable plastic material, for example, polycarbonate, and the like. The drug vial adapter sleeve 131 stops short of the drug vial stopper puncturing tip 112 in an initial set-up position of the liquid drug transfer assembly 100A such that the drug vial stopper puncturing tip 112 protrudes therebeyond. Thus, the drug vial stopper puncturing tip 112 contacts a drug vial stopper 24 before the drug vial adapter sleeve 131 on mounting the liquid drug transfer assembly 100A on the drug vial 20. </p><p id="p0050" num="0050"> Figures 4A to 4D show the use of the liquid drug transfer assembly</p><p id="p0051" num="0051">100A for liquid drug re constitution and administration as follows: </p><p id="p0052" num="0052"> Figure 4A shows the liquid drug transfer assembly 100A in its initial ready to use state for snap fitting on the drug vial 20 by downward depression of the former 100A towards the latter 20. </p><p id="p0053" num="0053"> Figure 4B shows initial downward depression of the liquid drug transfer assembly 100 A towards the drug vial 20 simultaneously causing the drug vial adapter skirt margin 129 to co-axially align the drug vial adapter 120 with the drug vial 20 and the drug vial stopper puncturing tip 112 to begin to puncture the drug vial stopper 24. </p><p id="p0054" num="0054"> Figure 4C shows complete snap fitting of the liquid drug transfer assembly 100A on the drug vial 20 including the complete penetration of the drug vial stopper penetrating member 110 through the drug vial stopper 24 to form a throughgoing puncture bore P. </p><p id="p0055" num="0055"> Figure 4D shows removal of the drug vial stopper penetrating member 110 from the drug vial 20 leaving the drug vial adapter 120 in place. The drug vial adapter sleeve 131 lines the puncture bore P to prevent the drug vial 
<!-- EPO <DP n="11"/>-->
 stopper 24 sealing itself. The drug vial adapter sleeve 131 also prevents any drug vial stopper remnants falling into the drug vial bottle to contaminate the vial contents. The needleless syringe 10 can be readily mounted on the female Luer connector 124 for injecting its contents into the drug vial bottle 21 for reconstitution or dilution purposes. </p><p id="p0056" num="0056"> Figure 5 shows the liquid drug transfer assembly 100A including a drug vial stopper puncturing member 110 having a liquid drug access port 114 with a longitudinal lumen 116 for enabling flow communication access to the drug vial bottle 21 on puncturing of the drug vial stopper 24. The liquid drug access port 114 can be optionally formed as a female Luer connector. The liquid drug access port 114 and/or longitudinal lumen 116 can be optionally formed with an in-line filter 117. </p><p id="p0057" num="0057"> Figure 6 shows an alternative embodiment of the drug vial adapter 120 including a drug vial adapter sleeve component 133 mounted on its drug vial adapter top surface 123. The drug vial adapter sleeve component 133 can be formed from a material different from the rest of the drug vial adapter 120. Suitable materials include inter alia elastomer materials, metal, neoprene fabrics, rubber, silicone, glass, and the like. </p><p id="p0058" num="0058"> Figure 7 shows a liquid drug transfer assembly 100B for use with an empty syringe 10, a drug vial 20 and a liquid vial 30. The liquid vial 30 has a longitudinal axis 30A and includes a liquid vial bottle 31 having a liquid vial shoulder 32 and a liquid drug vial opening 33 stopped by a liquid vial stopper 34. The liquid vial opening 33 has an uppermost outermost liquid vial rim 36. The liquid vial 30 contains a liquid component 37 for adding to the drug component 27. The liquid drug transfer assembly 100B is preferably packaged in a blister pack 101B shaped and dimensioned to snugly fit the liquid drug transfer assembly 100B inside and employed for operation of same. </p><p id="p0059" num="0059"> Figures 7 to 9 show the liquid drug transfer assembly 100B includes a drug vial adapter 120 and a liquid vial adapter 140. The liquid vial adapter 140 has a longitudinal liquid vial adapter axis 141 and includes a liquid vial adapter skirt 142 having a transversely directed liquid vial adapter top surface 143 
<!-- EPO <DP n="12"/>-->
 formed with a multitude of six downward depending liquid vial adapter flex members 144. The liquid vial adapter flex members 144 are provided with internal directed protrusions 146 for snap fitting under the liquid vial opening 33 and define a liquid vial adapter body portion 147 for snugly receiving the liquid vial opening 33. The liquid vial adapter flex members 144 define a liquid vial adapter skirt margin 148 outwardly flared with respect to the liquid vial adapter body portion 147 for assisting in guidance of the liquid vial adapter 140 on the liquid vial 30. </p><p id="p0060" num="0060"> The liquid vial adapter 140 also includes a dual ended dual lumen linear transfer spike 151 having a drug vial stopper puncturing member 152 for puncturing the drug vial stopper 24 and an opposite liquid vial stopper puncturing member 153 for puncturing the liquid vial stopper 34. The drug vial stopper puncturing member 152 extends from the liquid vial adapter top surface 143 away from the liquid vial adapter skirt 142. The drug vial stopper puncturing member 152 terminates at a drug vial stopper puncturing tip 154 which extends beyond the drug vial adapter sleeve 131 on mounting the liquid drug vial adapter 140 on the drug vial adapter 120. The liquid vial stopper puncturing member 153 extends from the liquid vial adapter top surface 143 into the liquid vial adapter skirt 142. The liquid vial stopper puncturing member 153 terminates at a liquid vial stopper puncturing tip 156. The dual ended dual lumen linear transfer spike 151 includes a liquid transfer lumen 157 for liquid transfer from the liquid vial 30 to the drug vial 20 and an air transfer lumen 158 for air transfer from the drug vial 20 to the liquid vial 30 for pressure equalization purposes. </p><p id="p0061" num="0061"> Figures 10A to 10G show the use of the liquid drug transfer assembly</p><p id="p0062" num="0062">100B for liquid drug reconstitution and administration as follows: </p><p id="p0063" num="0063"> Figure 10A shows the liquid drug transfer assembly 100B in its initial ready to use state for snap fitting on the drug vial 20 by downward depression of the former 100 towards the latter 20. </p><p id="p0064" num="0064"> Figure 10B shows complete snap fitting of the liquid drug transfer assembly 100B including the complete penetration of the drug vial stopper 
<!-- EPO <DP n="13"/>-->
 penetrating member 152 through the drug vial stopper 24 to form a throughgoing puncture bore P. </p><p id="p0065" num="0065"> Figure IOC shows inversion of the Figure 10B assemblage ready for snap fitting the liquid vial adapter 140 on the liquid vial 30. </p><p id="p0066" num="0066"> Figure 4D shows complete snap fitting of the liquid drug transfer assembly 100B including the drug vial 20 on the liquid vial 30. </p><p id="p0067" num="0067"> Figure 10E shows inversion of the Figure 10D assemblage for enabling gravitational liquid transfer from the liquid vial 30 to the drug vial 20 to form liquid drug contents LD in the drug vial 20 and venting from the drug vial 20 to the liquid vial 30. A user may gently agitate the inverted Figure 10D assemblage to facilitate reconstitution or dilution depending on the drug component and the liquid component. </p><p id="p0068" num="0068"> Figure 10F shows removal of the liquid vial adapter 140 together with its attached empty liquid vial 30 to leave the drug vial 20 with the liquid drug contents LD. The drug vial adapter sleeve 131 lines the puncture bore P to prevent the drug vial stopper sealing itself. The drug vial adapter sleeve 131 also prevents any drug vial stopper remnants falling into the drug vial bottle to contaminate the contents. </p><p id="p0069" num="0069"> Figure 10G shows use of the needleless syringe 10 for aspirating liquid drug contents LD from the drug vial 20 for administration purposes. </p><p id="p0070" num="0070"> Figures 11 to 14 show a liquid drug transfer assembly lOOC for use with an empty syringe 10, a drug vial 20 and a liquid vial 30. The liquid drug transfer assembly lOOC has a triple component construction including a drug vial adapter 160, a liquid vial adapter 170 and a liquid drug transfer device 180 having a longitudinal liquid drug transfer device axis 181. The liquid drug transfer assembly lOOC is preferably packaged in a blister pack 101C shaped and dimensioned to snugly fit the liquid drug transfer assembly lOOC inside and employed for operation of same. </p><p id="p0071" num="0071"> The drug vial adapter 160 has the same construction as the drug vial adapter 120 and therefore similar parts are likewise numbered. The drug vial adapter 160 differs from the drug vial adapter 120 insofar as the former 160 
<!-- EPO <DP n="14"/>-->
 includes an opposite pair of drug vial adapter flex members 161 formed with throughgoing drug vial leg tip apertures 162 in the region of the drug vial adapter body portion 128. Also, the drug vial adapter flex members 161 have smooth external surfaces 163 in the region of the drug vial adapter skirt margin 129 as opposed to the ridged surfaces of the drug vial adapter flex members 126. </p><p id="p0072" num="0072"> The liquid vial adapter 170 has the same construction as the liquid vial adapter 140 and therefore similar parts are likewise numbered. The liquid vial adapter 170 differs from the liquid vial adapter 140 insofar as the former 170 includes an opposite pair of liquid vial adapter flex members 171 formed with throughgoing liquid vial leg tip apertures 172 in the region of the liquid vial adapter body portion 147. Also, the liquid vial adapter flex members 171 have smooth external surfaces 173 in the region of the liquid vial adapter skirt margin 148 as opposed to the ridged surfaces of the liquid drug vial adapter flex members 144. </p><p id="p0073" num="0073"> And additionally, the liquid vial adapter 170 is formed without the dual ended dual lumen linear transfer spike 151 and instead has an upright tubular member 174 extending from the liquid vial adapter top surface 143 away from the liquid vial adapter skirt 142. The tubular member 174 includes a transversely directed flange 176. </p><p id="p0074" num="0074"> The liquid drug transfer device 180 has a similar construction to the dual ended dual lumen linear transfer spike 151 and therefore similar parts are likewise numbered. The liquid drug transfer device 180 includes a drug vial stopper puncturing member 152 terminating at a drug vial stopper puncturing tip 154 and an opposite liquid vial stopper puncturing member 153 terminating at a liquid vial stopper puncturing tip 156. The liquid drug transfer device 180 includes a liquid transfer lumen 157 and an air transfer lumen 158. The liquid transfer lumen 157 has a larger lumen cross section area than the air transfer lumen 158. The liquid transfer lumen 157 has a generally crescent transverse cross section which partially wraps around the air transfer lumen 158 thereby 
<!-- EPO <DP n="15"/>-->
 reducing the overall transfer spike cross sectional area for facilitating puncturing of the drug and liquid vial stoppers 24 and 34. </p><p id="p0075" num="0075"> The liquid drug transfer device 180 is additionally formed with a transverse directed spacing collar 182 rigidly mounted midway therealong, a pair of longitudinal directed drug vial legs 183 hinged on the spacing collar 182 and extending co-directional with and spaced apart from the drug vial stopper puncturing member 152 and a pair of longitudinal directed liquid vial legs 184 hinged on the spacing collar 182 and extending co -directional with and spaced apart from the liquid vial stopper puncturing member 153. The drug vial legs 183 terminate at drug vial leg tips 186 co-extensive with and inwardly protruding toward the drug vial stopper puncturing tip 154. The drug vial leg tips 186 are intended to be initially inserted into the throughgoing apertures 162. The liquid vial legs 184 terminate at liquid vial leg tips 187 co-extensive with and inwardly protruding toward the liquid vial stopper puncturing tip 156. The liquid vial leg tips 187 are intended to be initially inserted into the throughgoing apertures 172. </p><p id="p0076" num="0076"> The liquid vial legs 184 are preferably each formed with a pair of outwardly directed liquid vial leg protrusions 188 for bearing against the blister pack lOlC's internal surface 102 for assisting in the snap fitting of the liquid drug transfer assembly lOOC on the drug vial 20. </p><p id="p0077" num="0077"> The liquid drug transfer assembly lOOC includes a snap fit arrangement 190 for mechanically attaching the liquid vial adapter 140 to the spacing collar 182 on snap fitting the liquid vial adapter 140 on the liquid vial 30. The snap fit arrangement 190 is constituted by the tubular member 174 and the spacing collar 182 having a pair of snap members 191 for snap fitting on the transversely directed flange 176. </p><p id="p0078" num="0078"> Figures 15A to 15E show the operation of the liquid drug transfer assembly lOOC for snap fitting on the drug vial 20. </p><p id="p0079" num="0079"> Figure 15A shows the liquid drug transfer assembly lOOC co-axial with the drug vial 20 ready for snap fitting thereon. 
<!-- EPO <DP n="16"/>-->
 Figure 15B shows an initial downward depression of the liquid drug transfer assembly lOOC toward the drug vial 20. The drug vial leg tips 186 urge the drug vial adapter skirt margin 129 to co-axially align the drug vial adapter 120 with the drug vial 20 and the drug vial stopper puncturing tip 156 to begin to puncture the drug vial stopper 24. </p><p id="p0080" num="0080"> Figure 15C shows further downward depression of the liquid drug transfer assembly lOOC towards the drug vial 20 leading to complete snap fitting of the drug vial adapter 120 on the drug vial 20 and complete puncturing of the drug vial stopper 24 to form a throughgoing puncture bore P. The drug vial adapter sleeve 131 lines the follows the puncture bore P. The drug vial rim 26 begins to urge the drug vial leg tips 186 outwardly from their respective drug vial leg tip apertures 162. </p><p id="p0081" num="0081"> Figure 15D shows still further downward depression of the liquid drug transfer assembly lOOC towards the drug vial 20 to cause the drug vial leg tips 186 to leave their respective drug vial leg tip apertures 162 such that the liquid drug transfer device 180 is free to effect a sliding downward movement relative to the drug vial adapter 120. The drug vial leg tips 186 begin to slide down the smooth external surfaces 163 of their respective drug flex members 161. </p><p id="p0082" num="0082"> Figure 15E shows yet still further downward depression of the liquid drug transfer assembly lOOC towards the drug vial 20 leading to the drug vial leg tips 186 resting on the drug vial adapter skirt margin 129. </p><p id="p0083" num="0083"> The liquid drug transfer assembly lOOC snap fits onto the liquid vial 30 in a similar manner as it snap fits onto the drug vial 20. The liquid drug transfer device 180 additionally snap fits on the liquid vial adapter 140 for enabling convenient removal of the two components and the empty liquid vial 30 after forming the liquid drug contents in the drug vial 20. </p><p id="p0084" num="0084"> Figure 15F shows the operation of the snap fit arrangement 190, namely, the snap fit members 191 snapping onto the tubular member 174's flange 176. </p><p id="p0085" num="0085"> Figures 16A to 16G show the use of the liquid drug transfer assembly lOOC for liquid drug reconstitution and administration as follows: 
<!-- EPO <DP n="17"/>-->
 Figure 16A shows the liquid drug transfer assembly lOOC in its initial ready to use state for snap fitting on the drug vial 20 by downward depression of the former 100 towards the latter 20. </p><p id="p0086" num="0086"> Figure 16B shows the downward depression of the liquid drug transfer assembly lOOC towards the drug vial 20 causes the liquid drug transfer device 180 to urge the drug vial adapter 120 downwards to snap fit on the drug vial 20 and the drug vial puncturing member 152 to puncture the drug vial stopper 24 and the drug vial adapter sleeve 131 to line the puncture bore P. Also, the downward movement of the liquid drug transfer device 180 causes the drug vial leg tips 186 to be urged outward from the drug vial adapter 120 and rest on the drug vial adapter skirt margin 129. </p><p id="p0087" num="0087"> Figure 16C shows inversion of the Figure 6B assemblage for snap fitting on the liquid vial 30. </p><p id="p0088" num="0088"> Figure 16D shows the downward depression of the liquid drug transfer assembly lOOC towards the drug vial 30 causes the liquid drug transfer device 180 to urge the liquid vial adapter 140 downwards to snap fit on the liquid vial 30 and the liquid vial puncturing member 153 to puncture the liquid vial stopper 24. Also, the downward movement of the liquid drug transfer device 180 causes the liquid vial leg tips 187 to be urged outward from the liquid vial adapter 140 and rest on the liquid vial adapter skirt margin 148. The downward movement also causes the actuation of the snap fit arrangement 190 between the liquid drug transfer device 180 and the liquid drug adapter 140. </p><p id="p0089" num="0089"> Figure 16E shows inversion of the Figure 16D assemblage for enabling gravitational liquid transfer from the liquid vial 30 to the drug vial 20 to form liquid drug contents LD in the drug vial 20 and venting from the drug vial 20 to the liquid vial 30. A user may gently agitate the inverted Figure 16D assemblage to facilitate reconstitution or dilution of the liquid drug contents LD. </p><p id="p0090" num="0090"> Figure 16F shows the drug vial adapter 120 mounted on the drug vial 20 containing liquid drug contents LD after removal of the liquid drug transfer 
<!-- EPO <DP n="18"/>-->
 device 180 together with the liquid drug adapter 140 and its attached empty liquid vial 30. </p><p id="p0091" num="0091"> Figure 16G shows use of the needleless syringe 10 for aspirating liquid drug contents LD from the drug vial 20 for administration purposes. </p><p id="p0092" num="0092">While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications, and other applications of the invention can be made within the scope of the appended claims. 
</p></description><claims mxw-id="PCLM45846703" ref-ucid="WO-2012143921-A1" lang="EN" load-source="patent-office"><claim id="clm-0001" num="1"><!-- EPO <DP n="19"/>--><claim-text/><claim-text>CLAIMS: </claim-text><claim-text>I. A liquid drug transfer assembly for use with a drug vial including a drug vial bottle containing a drug component and having a drug vial opening stopped by a drug vial stopper, the liquid drug transfer assembly comprising:</claim-text><claim-text>(a) a drug vial stopper puncturing member with a drug vial stopper puncturing tip for puncturing the drug vial stopper; and </claim-text><claim-text> (b) a drug vial adapter having a longitudinal drug vial adapter axis and including a drug vial adapter skirt having a transversely directed drug vial adapter top surface formed with an upright drug vial adapter port, a drug vial adapter body portion for snugly receiving the drug vial opening and a drug vial adapter skirt margin remote from said drug vial adapter top surface, and a drug vial adapter sleeve downward depending from said drug vial adapter top surface opposite said upright drug vial adapter port and in flow communication therewith, </claim-text><claim-text> said drug vial adapter being slidingly disposed on said drug vial stopper puncturing member such that said drug vial stopper puncturing tip protrudes beyond said drug vial adapter sleeve, </claim-text><claim-text> the arrangement being such that on mounting the liquid drug transfer assembly on the drug vial, said drug vial stopper puncturing member punctures the drug vial stopper to form a throughgoing puncture bore and said drug vial adapter sleeve lines said puncture bore whereby, on withdrawal of said drug vial stopper puncturing member from said puncture bore, said drug vial adapter sleeve prevents the drug vial stopper from sealing itself thereby enabling flow communication between said drug vial adapter port and the drug vial bottle. </claim-text></claim><claim id="clm-0002" num="2"><claim-text>2. The assembly according to claim 1 wherein said drug vial adapter skirt, said drug vial adapter port and said drug vial adapter sleeve are formed as a single injection plastic molded unit from the same plastic material. <!-- EPO <DP n="20"/>--> </claim-text></claim><claim id="clm-0003" num="3"><claim-text>3. The assembly according to claim 1 wherein said drug vial adapter sleeve is mounted on said drug vial adapter skirt and is formed from a different material therefrom. </claim-text></claim><claim id="clm-0004" num="4"><claim-text>4. The assembly according to any one of claims 1 to 3 wherein said drug vial stopper puncturing member includes a liquid drug access port and a longitudinal lumen for enabling flow communication access to the drug vial bottle on said puncturing of the drug vial stopper. </claim-text></claim><claim id="clm-0005" num="5"><claim-text>5. The assembly according to claim 4 wherein drug vial stopper puncturing member includes an in-line filter. </claim-text></claim><claim id="clm-0006" num="6"><claim-text>6. The assembly according to any of claims 1 to 3 for additional use with a liquid vial including a liquid vial bottle containing a liquid component and having a liquid vial opening stopped by a liquid vial stopper, the liquid component intended for adding to the drug component to form liquid drug contents, </claim-text><claim-text> wherein said drug vial stopper puncturing member is formed as a dual ended dual lumen linear transfer spike integrally formed with a liquid vial adapter including a liquid vial adapter skirt having a transversely directed liquid vial adapter top surface and a liquid vial adapter body portion for snugly receiving the liquid vial opening therein, </claim-text><claim-text> said dual ended dual lumen linear transfer spike including a liquid vial stopper puncturing member opposite said drug vial stopper puncturing member, said liquid vial stopper puncturing member having a liquid vial stopper puncturing tip for puncturing the liquid vial stopper on mounting the liquid vial adapter on the liquid vial thereby enabling simultaneous gravitational flow of liquid component from the liquid vial to the drug vial and air flow from the drug vial to the liquid vial on forming an upright assemblage of an uppermost liquid vial and a lowermost drug vial for forming liquid drug contents in the drug vial for administration purposes on removal of the liquid vial adapter from the drug vial adapter. <!-- EPO <DP n="21"/>--> </claim-text></claim><claim id="clm-0007" num="7"><claim-text>7. The assembly according to any one of claims 1 to 3 for additional use with a liquid vial including a liquid vial bottle containing a liquid component and having a liquid vial opening stopped by a liquid vial stopper, the liquid component intended for adding to the drug component to form liquid drug contents, said </claim-text><claim-text> wherein said drug vial stopper puncturing member is formed as one end of a dual ended dual lumen linear transfer spike having a longitudinal axis and including </claim-text><claim-text> i) an opposite directed liquid vial stopper puncturing member with a liquid vial stopper puncturing tip for puncturing the liquid vial stopper, </claim-text><claim-text> ii) a transverse directed spacing collar rigidly mounted on said linear transfer spike, </claim-text><claim-text> iii) at least two longitudinal directed drug vial legs mounted on said spacing collar and extending co-directional with and spaced apart from said drug vial stopper puncturing member, </claim-text><claim-text> said at least two drug vial legs terminating at drug vial leg tips coextensive with and inwardly protruding toward said drug vial stopper puncturing tip, </claim-text><claim-text> iv) at least two longitudinal directed liquid vial legs mounted on said spacing collar and extending co-directional with and spaced apart from said liquid vial stopper puncturing member, </claim-text><claim-text> said at least two liquid vial legs terminating at liquid vial leg tips coextensive with and inwardly protruding toward said liquid vial stopper puncturing tip, </claim-text><claim-text> said drug vial adapter being slidingly mounted on said drug vial stopper puncturing member with said drug vial adapter top surface towards said spacing collar and said drug vial adapter skirt margin remote therefrom, </claim-text><claim-text> said drug vial adapter skirt having drug vial leg tip apertures for initially receiving said drug vial leg tips for initially spacing said drug vial adapter from said spacing collar such that said drug vial adapter skirt margin is further from said spacing collar than said drug vial puncturing tip whereby, on sliding said <!-- EPO <DP n="22"/>--> drug vial adapter towards said spacing collar, said drug vial adapter skirt mounts on the drug vial opening for enclosing the drug vial opening in said drug vial adapter body portion, said drug vial stopper puncturing member punctures the drug vial stopper for flow communication with the drug vial bottle and said drug vial leg tips slide along said drug vial adapter skirt towards said drug vial adapter skirt margin; and </claim-text><claim-text> (c) a liquid vial adapter including a liquid vial skirt adapter having a transversely directed liquid vial adapter top surface formed with a liquid vial adapter body portion for snugly receiving the liquid vial opening and a liquid vial adapter skirt margin, </claim-text><claim-text> said liquid vial adapter being slidingly disposed on said liquid vial stopper puncturing member with said liquid vial adapter top surface towards said spacing collar and said liquid vial adapter skirt margin remote therefrom, said liquid vial adapter skirt having liquid vial leg tip apertures for initially receiving said liquid vial leg tips for initially spacing said liquid vial adapter from said spacing collar such that said liquid vial adapter skirt margin is further from said spacing collar than said liquid vial stopper puncturing tip whereby, on sliding said liquid vial adapter towards said spacing collar, said liquid vial adapter skirt mounts on the liquid vial opening for enclosing the liquid vial opening in said liquid vial adapter body portion, said liquid vial stopper puncturing member punctures the liquid vial stopper for flow communication with the liquid vial bottle and said liquid vial leg tips slide along said liquid vial adapter skirt towards said liquid vial adapter skirt margin. </claim-text></claim><claim id="clm-0008" num="8"><claim-text>8. The assembly according to claim 7 wherein said liquid drug transfer device and said liquid vial adapter have a snap fit arrangement for mechanically attaching said liquid drug transfer device to said liquid vial adapter on mounting said liquid vial adapter on the liquid vial. </claim-text></claim><claim id="clm-0009" num="9"><claim-text>9. The assembly according to claim 8 wherein said snap fit arrangement is constituted by said liquid vial adapter port having a longitudinal directed <!-- EPO <DP n="23"/>--> tubular member directed towards said spacing collar and said spacing collar having at least one snap member for snap fitting on said tubular member. </claim-text></claim><claim id="clm-0010" num="10"><claim-text>10. The assembly according to any one of claims 7 to 9 wherein said drug vial adapter skirt margin is outwardly flared with respect to said drug vial adapter body portion and includes smooth external surfaces for facilitating said sliding of said drug vial leg tips towards said drug vial adapter skirt margin. </claim-text></claim><claim id="clm-0011" num="11"><claim-text>11. The assembly according to any one of claims 7 to 10 wherein said liquid vial adapter skirt margin is outwardly flared with respect to said liquid vial adapter body portion and includes smooth external surfaces for facilitating said sliding of said liquid vial leg tips towards said liquid vial adapter skirt margin. </claim-text></claim><claim id="clm-0012" num="12"><claim-text>12. The assembly according to any one of claims 7 to 11 wherein the liquid drug transfer assembly is packaged in a blister pack and each liquid vial leg has at least one outwardly directed liquid leg vial protrusion for bearing against an internal surface of said blister pack. </claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
